INVITAE
Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world’s genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. What’s our plan? It takes three steps: --Make genetic testing more ... affordable and accessible than ever before. --Build a secure and trusted genome management infrastructure. --Design a new global community for sharing genetic information to advance science and medicine. Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.
INVITAE
Industry:
Biotechnology Genetics Health Care
Founded:
2010-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.invitae.com
Total Employee:
501+
Status:
Active
Contact:
+1 (415) 930-4018
Email Addresses:
[email protected]
Total Funding:
1.99 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Domain Not Resolving Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Alector
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Aperiomics
Advancing healthcare and revolutionizing infection testing for improved global health
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Generation Bio
Generation Bio develops a breakthrough class of genetic medicines based on its proprietary GeneWave technology.
Helix
Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Inivata
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.
Veritas Genetics
Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-07 | Ciitizen | Ciitizen acquired by Invitae | 325 M USD |
| 2021-04-05 | Genosity | Genosity acquired by Invitae | 200 M USD |
| 2021-02-19 | One Codex | One Codex acquired by Invitae | N/A |
| 2020-06-22 | ArcherDX | ArcherDX acquired by Invitae | 1.4 B USD |
| 2020-03-10 | Diploid | Diploid acquired by Invitae | 95 M USD |
| 2020-03-10 | Genelex | Genelex acquired by Invitae | 20.7 M USD |
| 2020-03-10 | YouScript | YouScript acquired by Invitae | 79.3 M USD |
| 2019-11-11 | Clear Genetics | Clear Genetics acquired by Invitae | N/A |
| 2019-07-11 | Jungla | Jungla acquired by Invitae | 50 M USD |
| 2019-01-17 | Singular Bio | Singular Bio acquired by Invitae | N/A |
Investors List
SoftBank
SoftBank investment in Post-IPO Debt - Invitae
Decheng Capital
Decheng Capital investment in Series F - Invitae
Deerfield Capital Management
Deerfield Capital Management investment in Series F - Invitae
Redmile Group
Redmile Group investment in Series F - Invitae
Three Leaf Ventures
Three Leaf Ventures investment in Series F - Invitae
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series F - Invitae
Sofinnova Investments
Sofinnova Investments investment in Series F - Invitae
OrbiMed
OrbiMed investment in Series F - Invitae
J.P. Morgan Securities Inc.
J.P. Morgan Securities Inc. investment in Series F - Invitae
Genomic Health
Genomic Health investment in Series F - Invitae
Official Site Inspections
http://www.invitae.com Semrush global rank: 105.67 K Semrush visits lastest month: 923.54 K
- Host name: ec2-54-159-207-63.compute-1.amazonaws.com
- IP address: 54.159.207.63
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Invitae"
About Invitae: Our story, mission & corporate …
Through Invitae, your de-identified data are advancing medical genetics and enabling the use of “real world” data to aid the development of new treatments. In 2023, Invitae released our updated Data use transparency and impact report , …See details»
Invitae - Wikipedia
Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million. See details»
Contact info: Invitae phone numbers & email by region
Invitae's team of experts is here to support you every step of the way. Find contact information, including email and phone numbers. Get in touch today. Exciting news: Invitae joins Labcorp …See details»
Invitae Announces Leadership Transition
Jul 18, 2022 "Invitae is a special organization with talented team members, powerful growth drivers and a visionary path to deliver innovative genomics to the world. I'm excited to work together with the Board and management team to …See details»
Invitae - Invitae Announces Strategic Business …
Jul 18, 2022 Invitae will operate as a leaner, more focused organization, targeting both a stronger and more profitable testing services business as well as the completion and launch of a genome management platform, which will …See details»
Invitae - LinkedIn
Invitae, now part of Labcorp, is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology.See details»
Invitae - Invitae and ArcherDX to create a global leader …
Jun 22, 2020 Under the terms of the agreement, Invitae will acquire ArcherDX for upfront consideration consisting of 30 million shares of Invitae common stock and $325 million in cash, plus up to an additional 27 million shares of Invitae …See details»
Labcorp Expands Genetic Testing with Invitae Acquisition
Advancing genetic insights to transform medicine together. Labcorp welcomes the Invitae team, scientific leaders and pioneers in the development and adoption of genetic testing, who have …See details»
Invitae - Crunchbase Company Profile & Funding
Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, …See details»
Invitae - CancerGene Connect
Welcome! To access your organization please use the following URL format or contact your healthcare provider. https://cgc.invitae.com/YOUR_ORGANIZATIONSee details»
Invitae Company Profile - Office Locations, Competitors ... - Craft
Apr 17, 2024 Invitae has 5 employees at their 1 location and $516.3 m in annual revenue in FY 2022. See insights on Invitae including office locations, competitors, revenue, financials, …See details»
Profile | Sign In - Invitae
Invitae’s mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's LinkedIn Page Invitae's Instagram PageSee details»
Invitae - Invitae to acquire Genosity to accelerate access to ...
Apr 5, 2021 Unrelated to the Genosity transaction, Invitae reported inducement grants in connection with the addition of certain assets and key personnel from a small organization …See details»
Medical genetic testing that experts trust - Invitae
Yes, you can contact Invitae today by visiting our contact us page to find contact information for client services and billing specialists. To speak directly with client services, email …See details»
How Does Invitae Work? – CBM - canvasbusinessmodel.com
2 days ago [cbm_blg_rlnkng]Invitae is a pioneering genetic testing company that is revolutionizing the healthcare industry with its innovative approach. By offering a wide range of …See details»
Account & ordering portal faqs | For providers - Invitae
Yes, Invitae supports ordering on behalf of multiple organizations. To change the organization associated with a specific order: Start your order and complete the required fields until you …See details»
Invitae - Introducing Invitae Digital Health--A Personalized Health ...
Mar 29, 2022 Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Invitae Digital Health—a connected digital health platform that informs health …See details»
Log In - Invitae
By entering this website you acknowledge and agree to the following terms and notices. Privacy Statement Terms of Service HIPAA © 2024 - OMMDOM, Inc. All Rights ...See details»
Patient portal & account faqs | For Individuals - Invitae
If your physician does not release the results then Invitae will automatically make your report available within 30 days of your request. Invitae’s mission is to bring comprehensive genetic …See details»